pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·3h ago·1 min read
save

Bon Secours Mercy Health receives $1.1 billion from Ensemble Health Partners stake in 2026

Aug 18, 2026·read at STAT ↗DealPositive

Bon Secours Mercy Health, a nonprofit system based in Cincinnati, reported that it has collected more than $1 billion in cash this year from its minority stake in Ensemble Health Partners, a medical billing firm.

The latest payment was a $671 million distribution received when Ensemble signed a new private equity sponsor, adding to a $427 million payout recorded in February.

The two distributions were disclosed in the system’s second‑quarter financial report covering the period ending June 30, showing that the cash inflows from the stake far exceed the health system’s operating income to date.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Nonprofit health system raked in $1.1 billion this year from stake in medical billing firm”

read at STAT ↗
511 words · retrieved 2h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Protara Therapeutics, Inc.7CYCLE
drugs
(aeruginascin + baeocystin + psilocybin)MYCO-003Oral PsilocybinPsilocybin (Microneedle Patch)psilocybin
topics
Ophthalmology

related stories

  • 5h agoSTAT+: Real-world psilocybin data suggest need for close monitoringSTAT
  • Jul 30Chutes & Ladders—Legend CEO departs without successor in placeFierce Biotech
  • Jul 18‘A rising tide scenario’: Why other Big Pharmas could follow Lilly into psychedelicsFierce Biotech
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Apr 30Trump drops Casey Means as surgeon general nominee, opts for radiologist Nicole SaphierSTAT